The Significance of @entity1931 in a XXXX With Chronic Pelvic Pain.

@entity1 @entity1931 @entity2708 @entity548 @entity409 @entity2371 @entity158 @entity925
UNASSIGNED: Background: This is a case report of sensory assessment in a @entity1 with severe chronic @entity2371 following uterine artery embolization, and a discussion of a commonly observed sensory manifestation ( @entity1931 ) associated with chronic @entity2371 due to gynaecological conditions. Allodynia, as a common sensory abnormality can be readily detected at the bedside and represents the development of @entity158 sensitization. Emergence of abdominal and perineal @entity1931 (assessed by @entity2708 swap stroking and/or questionnaire) is associated with the development of the clinical features of sensitization: continuous @entity2371 , @entity925 , and reduced pressure @entity158 thresholds. Case: A uterine artery embolization was performed on a 42-year-old @entity1 to treat a postpartum @entity548 . The @entity1 experienced severe @entity158 immediately following the procedure, and it had persisted for one year when she was referred for chronic unrelenting @entity158 . She was found to have extensive @entity1931 , @entity409 , and reduced @entity158 thresholds. A hysterectomy was undertaken. As the @entity158 persisted, botulinum toxin was administered to the lower abdomen in the region of reduced @entity158 thresholds. Partial resolution of @entity158 , physical limitation, and @entity1931 resolved one year after the hysterectomy and shortly after the injections of four tender regions of the anterior cutaneous nerves with 2.5 and 5.0 IU of botulinum toxin. Conclusion: Testing for @entity1931 is a validated bedside test for @entity158 sensitization. A clinical trial of botulinum toxin is indicated for the management of chronic @entity2371 associated with @entity1931 and @entity158 sensitization.
